The number of Latinos with HIV or AIDS in Chicago grew nearly 17% between 2020 to 2024 while other racial groups saw a drop, ...

Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...

The management of HIV infection has undergone a dramatic evolution over recent decades, with improved access to antiretroviral therapy (ART) fundamentally altering the clinical profile of patients and ...

As in the immunocompetent child, AOM is common in the first year of life, but with increasing age the HIV-infected child has a higher annual incidence of infections than the immunocompetent child.

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...

Compared to daily oral pre-exposure prophylaxis (PrEP), lenacapavir reduces the number of new HIV infections by many more; causes slightly fewer serious unwanted effects; and results in little to no ...

AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer—among the ...

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus ...

Senior medical practitioners have outlined the potential benefits of a newly introduced Lenacapavir, a long-acting Human Immunodeficiency Virus prevention injection, saying it could significantly ...

By Ben Ezeamalu and Jennifer Rigby MAKURDI, Nigeria, March 31 (Reuters) - For several months last year, Josephine Angev ...